tiprankstipranks
Advertisement
Advertisement

HK:9939 Stock Latest News

Kintor Pharmaceutical Wins Strong Shareholder Backing at 2026 AGM
Company AnnouncementsKintor Pharmaceutical Wins Strong Shareholder Backing at 2026 AGM
24d ago
9939
Kintor Advances KT-939 Cosmetic Raw Material With Strong Safety Data and China Registration Push
PremiumCompany Announcements
Kintor Advances KT-939 Cosmetic Raw Material With Strong Safety Data and China Registration Push
1M ago
9939
Kintor Showcases Promising KX-826 Hair Loss Data as It Pursues First-in-Class Status
PremiumCompany Announcements
Kintor Showcases Promising KX-826 Hair Loss Data as It Pursues First-in-Class Status
1M ago
9939
Kintor CEO Boosts Stake, Signaling Confidence in Hair-Loss Drug Pipeline
PremiumCompany Announcements
Kintor CEO Boosts Stake, Signaling Confidence in Hair-Loss Drug Pipeline
1M ago
9939
Kintor Pharmaceutical Sets 2026 AGM to Approve Accounts, Board Changes and Share Issuance Mandate
PremiumCompany Announcements
Kintor Pharmaceutical Sets 2026 AGM to Approve Accounts, Board Changes and Share Issuance Mandate
2M ago
9939
Kintor Pharma to Rotate Auditor, Taps Rongcheng HK to Replace PwC in 2026
PremiumCompany AnnouncementsKintor Pharma to Rotate Auditor, Taps Rongcheng HK to Replace PwC in 2026
2M ago
9939
Kintor Pharmaceutical to Relocate Hong Kong Principal Office in 2026
Premium
Company Announcements
Kintor Pharmaceutical to Relocate Hong Kong Principal Office in 2026
2M ago
9939
Kintor Pharmaceutical Surges in E‑commerce and B2B Sales to Fund Core Drug Pipeline
Premium
Company Announcements
Kintor Pharmaceutical Surges in E‑commerce and B2B Sales to Fund Core Drug Pipeline
3M ago
9939
Kintor’s Cosmetics-Driven Revenue Soars but Loss Widens on Pipeline Shift
PremiumCompany Announcements
Kintor’s Cosmetics-Driven Revenue Soars but Loss Widens on Pipeline Shift
3M ago
9939
Kintor Pharmaceutical Delays Board Meeting to Approve 2025 Annual Results
PremiumCompany Announcements
Kintor Pharmaceutical Delays Board Meeting to Approve 2025 Annual Results
4M ago
9939
Kintor’s KX-826 Hits Phase III Goal in China AGA Trial, NDA Planned
PremiumCompany Announcements
Kintor’s KX-826 Hits Phase III Goal in China AGA Trial, NDA Planned
4M ago
9939
Kintor Ties Up With Chicmax to Commercialize KT-939 Whitening Ingredient and Fund Core Drug Pipeline
PremiumCompany Announcements
Kintor Ties Up With Chicmax to Commercialize KT-939 Whitening Ingredient and Fund Core Drug Pipeline
4M ago
9939
Kintor Partners With Fonow Medicine to Commercialize KT-939 Functional Cosmetics in China
PremiumCompany AnnouncementsKintor Partners With Fonow Medicine to Commercialize KT-939 Functional Cosmetics in China
4M ago
9939
Kintor Reaffirms Drug R&D Focus as Cosmetics Remain Ancillary Revenue Stream
Premium
Company Announcements
Kintor Reaffirms Drug R&D Focus as Cosmetics Remain Ancillary Revenue Stream
5M ago
9939
Kintor CEO Boosts Stake as Company Doubles Down on Dermatology and Cosmetic Expansion
Premium
Company Announcements
Kintor CEO Boosts Stake as Company Doubles Down on Dermatology and Cosmetic Expansion
6M ago
9939
Kintor Pharmaceutical Sets March Board Meeting to Approve 2025 Annual Results
PremiumCompany Announcements
Kintor Pharmaceutical Sets March Board Meeting to Approve 2025 Annual Results
6M ago
9939
Kintor Strikes Exclusive Deal to Market Anti-Hair Loss Foam in Mainland China
PremiumCompany Announcements
Kintor Strikes Exclusive Deal to Market Anti-Hair Loss Foam in Mainland China
6M ago
9939
Kintor Pharmaceutical Announces Board Composition and Roles
PremiumCompany Announcements
Kintor Pharmaceutical Announces Board Composition and Roles
7M ago
9939
Kintor Pharmaceutical Announces Board Changes
PremiumCompany Announcements
Kintor Pharmaceutical Announces Board Changes
7M ago
9939
Kintor Pharmaceutical Completes Share Subscription to Fund Clinical Trials
PremiumCompany AnnouncementsKintor Pharmaceutical Completes Share Subscription to Fund Clinical Trials
8M ago
9939
Kintor Pharmaceutical to Raise HK$49.78 Million Through Share Subscription
Premium
Company Announcements
Kintor Pharmaceutical to Raise HK$49.78 Million Through Share Subscription
8M ago
9939
Kintor Pharmaceutical Advances KT-939 in Long-Term Safety Trial
Premium
Company Announcements
Kintor Pharmaceutical Advances KT-939 in Long-Term Safety Trial
10M ago
9939

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >